D-Wave Quantum saw an impressive price surge of 101% last week, likely influenced by pivotal recent events. The announcement on March 12 of a groundbreaking achievement, where their annealing quantum computer outperformed a classical supercomputer, highlighted the company's innovative capabilities in quantum supremacy. This could have bolstered investor confidence, marking a significant leap in technological applications related to medical imaging and materials discovery. Despite reporting a substantial net loss for Q4 2024—a 436% increase to $86 million—the news of expected Q1 FY 2025 revenue exceeding $10 million, largely from their Advantage annealing quantum computer sales, might have spurred optimism. As market indexes like the Nasdaq gained ground amid investor anticipation surrounding the Federal Reserve's policy announcements, it created a favorable environment for tech stocks. This broader trend, along with D-Wave's recent developments, potentially contributed to the extraordinary movement in their share price.
We've discovered 3 possible red flags for D-Wave Quantum (1 doesn't sit too well with us!) that you should be aware of before investing here.
The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 22 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
Over the last year, D-Wave Quantum experienced a remarkable total shareholder return of 397.70%. This growth far outpaced the US Software industry's decline of 0.8% and the broader US market's gain of 8.1%. One pivotal moment was the launch of a new hybrid quantum solver in June 2024, which expanded computational capabilities significantly. The subsequent addition to various Russell Indexes in July 2024 further boosted its visibility among investors. Meanwhile, a strategic alliance with Japan Tobacco Inc.'s pharmaceutical division in December 2024 marked an important step in expanding D-Wave's applications in drug discovery through Quantum AI. These developments collectively strengthened investor confidence, contributing to the impressive return.
However, the company's balance sheet illustrated some challenges, with a sizable net loss for FY 2024, as losses widened to US$143.88 million. Despite this, an influential partnership with Jülich Supercomputing Centre in February 2025 underscored their competitive edge in high-performance computing, signaling confidence in D-Wave's innovative potential. These collaborations and technological advancements have shaped the company's trajectory significantly over the past year.
Understand D-Wave Quantum's track record by examining our performance history report.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NYSE:QBTS.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Comments